Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
BB Biotech ( (CH:BION) ) has shared an announcement.
BB Biotech AG has been included in the SPI ESG Index of the SIX Swiss Exchange, marking a significant milestone in its commitment to responsible investing and sustainable corporate governance. This inclusion not only enhances the company’s visibility among ESG-focused investors but also reinforces its strategic focus on innovative biotechnology companies that provide financial value and contribute positively to society.
The most recent analyst rating on (CH:BION) stock is a Buy with a CHF66.00 price target. To see the full list of analyst forecasts on BB Biotech stock, see the CH:BION Stock Forecast page.
More about BB Biotech
BB Biotech AG is an investment company based in Schaffhausen, Switzerland, and is listed on the Swiss and German stock exchanges. Since 1993, it has focused on investing in innovative drug development companies primarily located in the USA and Western Europe. The company is recognized as a leading investor in the biotechnology sector, with its investment strategy and decisions guided by a competent board of directors and an experienced investment management team from Bellevue Asset Management AG.
YTD Price Performance: 8.46%
Average Trading Volume: 83,494
Technical Sentiment Signal: Hold
Current Market Cap: CHF2B
See more insights into BION stock on TipRanks’ Stock Analysis page.